| Similar Articles |
|---|
 |
Chemistry World
January 15, 2008
Hepeng Jia |
Huge Project to Boost Chinese Drug Development The Chinese government has agreed a multi-billion drug development funding program to boost innovation in its generics-dominated pharmaceutical sector.   |
Inc.
September 2008 |
Start-Up Capital Survey results about how start-ups obtain funding. |
Chemistry World
August 19, 2009
Hepeng Jia |
China drug scheme funds out of reach Funding through China's multi-billion yuan key drug development scheme could become harder to come by over the next five-year term of the program, according to a senior representative. |
Chemistry World
October 28, 2014
Hepeng Jia |
China's science academy launches new reform drive The Chinese Academy of Sciences, the nation's largest research body, is to reshuffle its 100 plus research institutes and change the way it rewards scientists. |
Bio-IT World
October 14, 2004
Michael Greeley |
Go East Business is great in China, and the government is strongly encouraging the local biotech industry. |
Chemistry World
June 29, 2009
Anna Lewcock |
Going green with white biotech Industrial biotech has also been growing steadily in the chemicals sector, and in 2007 six per cent of all chemical sales were generated with the help of enzymes - so-called 'white' biotech. |
IndustryWeek
July 1, 2008
Jill Jusko |
Are Venture Capitalists Misplaying Nanotech? Nanotechnology funding is out of sync with returns. |
The Motley Fool
August 25, 2005 |
Venture Capitalists They're not in the news as much, but they're still around -- and important. |
| Knowledge@Wharton |
The Benefits Are Mutual in New Wave of Biotech/Pharma Alliances The spat that erupted between pharma giant Bristol-Myers Squibb and biotech firm ImClone Systems over their partnership to develop a new cancer drug put the structure of alliances between discovery research firms and big drug makers under a microscope... |
Entrepreneur
November 2003
David Worrell |
Seed Money VC financing for early-stage companies is back in bloom. |
Chemistry World
April 4, 2012
Helen Carmichael |
Canada research budget boost costs the environment Canada's researchers and environmentalists are digesting the impacts of finance minister Jim Flaherty's 2012 budget. |
BusinessWeek
March 7, 2005
Arlene Weintraub |
Where VCs Fear To Tread Angel investors are filling a critical gap by providing early backing for biotechs. |
Chemistry World
October 24, 2007
Hepeng Jia |
China to Ramp up Nuclear Power China may dramatically increase the proportion of energy it gets from nuclear power in the near future, according to the energy expert charged with developing the country's new energy strategy. |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape. |
Chemistry World
May 30, 2014
Hepeng Jia |
China plans 'green' open access future Thousands of Chinese papers published in top journals will have to freely accessible within a year of publication. |
Entrepreneur
April 2007
Guy Kawasaki |
Go for the Gold If you're trying to get venture capital, follow these 10 steps to impressing investors, and you'll be on your way to the big time. |
Inc.
May 1, 2002
Kenneth Klee |
The Industry You Can't Afford to Miss After more than two decades of hype, hope, disappointment, and progress, the hundreds of mostly small, money-burning companies that make up the biotech industry are experiencing a decisive shift in their relationship with the giant, rich pharmaceutical companies... |
Job Journal
July 16, 2006
Julia Hollister |
Biotech Boom The biotech field offers promising jobs in a profession that's expanding faster than you can spell biotherapeutics. |
Entrepreneur
March 2007
Jennifer Pellet |
In Good Company Corporate VC funding's on the up. Could you be in the money? |
Chemistry World
November 20, 2007
Hepeng Jia |
China Leaps up Research League Table China has overtaken Japan and the UK to become the world's second largest producer of science and technology (S&T) papers. |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector |
Pharmaceutical Executive
December 1, 2010
Zhu Shen |
China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda |
InternetNews
November 5, 2009 |
Startup Software Spending Falls to 13-Year Low Investment in fledgling software companies reaches its lowest level in 13 years as clean tech and biotech spending surges. |
The Motley Fool
October 23, 2006
Jack Uldrich |
Is Microsoft on Drugs? If the company uses its new BioIT Alliance not simply to push its existing software, but also to better understand what biotech customers need and want, Microsoft's new drug habit could even provide its long-suffering shareholders a little high. |
Entrepreneur
January 2010
Carol Tice |
Are Venture Capitalists Becoming More Adventurous? VC funding seemingly stabilizes for most of the tech sector. |
Entrepreneur
July 2002
Tracy T. Lefteroff |
After The Flood With the flow of VC funding slowed to a trickle, let our list of the top 100 VC funds be your divining rod. |
Bio-IT World
June 15, 2003
Bob Violino |
Northeast Region Massachusetts: University and Research Hub... Connecticut: Investing in Bio Facilities... New York: Biotech Empire State... New Jersey: Still Big Pharma Country... Pennsylvania: Life Sciences, a Keystone Industry |
Bio-IT World
April 2006
Kevin Davies |
Microsoft Forges BioIT Alliance The software giant's fledgling alliance aims to bring together companies from a cross-section of the industry -- from biotech and Big Pharma to equipment manufacturers and software developers -- to collaborate on technology that will speed drug discovery. |
Pharmaceutical Executive
September 1, 2008
Zhu Shen |
Unleash the Dragon Concerns over quality? It's not stopping Big Pharma outsourcing and venture capital. |
Knowledge@Wharton
March 26, 2003 |
Health Care Finance Industry Plagued by Lack of Funding, Focus In today's health care finance environment, early financing rounds are harder to fund and the market for initial public financings is dead, with no revival expected anytime soon. |
Pharmaceutical Executive
May 1, 2005 |
Thought Leaders: Playing Field in Biotech/Pharma Partnerships Levels As infrastructure and business savvy within biotechs become increasingly sophisticated, the sector's relationship with pharma is taking on a new shape. An interview with industry veteran Lisa Drakeman on how to integrate cultures and processes and where pharma is falling short. |
BusinessWeek
November 10, 2003
Arlene Weintraub |
Biotech Startups: Take Your Time Until products are close to approval, the public shouldn't share the risk |
Chemistry World
August 21, 2013
Phillip Broadwith |
Two way traffic for Chinese drug licensing Chinese companies have trailed behind their Western counterparts in developing innovative new drugs. Very few of those inventions have been considered useful enough to be licensed by western companies. However, that appears to be changing. |
BusinessWeek
July 12, 2004
Kerry Capell |
These Biotechs Need Time To Ripen A rush to the IPO market in Europe won't do the biotech industry any good. |
Entrepreneur
May 2003
C.J. Prince |
Ray of Hope? VCs are optimistic about the coming year but are still holding on to their purse strings. |
Entrepreneur
July 2003
Lefteroff et al. |
The Thrill of the Chase Nowadays, it seems venture capitalists are an endangered species, but your chances of finding VC funding are better than you think. We'll help you track down investors with our 3rd Annual VC 100. |
Entrepreneur
April 2009
Asheesh Advani |
Know How Your VC Gets Paid The bear market brings several implications for startups looking for funding. |
Entrepreneur
June 2007 |
Reel 'Em In Do you have the right bait to entice investors? Get them hooked - and get money for your business - with these tips. |
Chemistry World
June 19, 2008
Hepeng Jia |
Chemistry dominates list of China's most influential papers The Thomson Reuters Research Fronts Award recognized a total of 24 key journal articles - including seven chemistry papers and two from the material sciences - for their outstanding contribution to international R&D. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Northwest Region Colorado: Biotech Summit in Denver... Utah: A Mecca for Genealogical Research... Washington State: Therapeutics and Diagnostics Niche... |
InternetNews
November 5, 2010 |
VC Spending Plummets But Software Still Tops The third quarter was a disappointing one for venture capital investment but a good number of new software companies have little to complain about. |
Chemistry World
February 2008
Nuala Moran |
The Chemistry of Private Equity Private equity has transformed the chemicals industry, but can it play the same role in high-risk R&D driven companies? |
Entrepreneur
January 2009
Brad Feld |
Perfect Your Pitch If you want to secure venture capital, avoid these 8 mistakes. |
Chemistry World
July 15, 2008
Hepeng Jia |
Testing Times for New Liver Drug AstraZeneca is set to start clinical trials of a liver cancer drug developed for Chinese patients. |
Entrepreneur
August 2008
Tracy T. Lefteroff |
High Rollers Venture capitalists showed entrepreneurs the big bucks in 2007. Could one of our top VC firms be looking for a business like yours this time around? |
Bio-IT World
April 2006
Michael A. Greeley |
The Good, The Bad, and The Ugly VCs will not support a sector where consistent compelling exits are not evident. Unfortunately, the bio-IT field still suffers from this. |
Bio-IT World
April 2006
Laura Huckabee-Jennings |
Southern Emergence Why Huntsville, Alabama, will be the next biotech hotbed. |
The Motley Fool
December 9, 2008
Tim Beyers |
Tech Bailout Is Oxymoronic Should the U.S.be concerned with offering emergency venture capital for struggling tech start-ups? |
Chemistry World
October 2007
Hepeng Jia |
High Hopes for Anti-Monopoly Law At a petrochemical seminar in Beijing, calls to break the monopoly on petroleum supplies held by two big State-owned oil giants -- China National Petroleum Corp (CNPC) and Sinopec -- were repeatedly applauded. |
Investment Advisor
February 2010
Jeff Joseph |
Venture Populist: Venture Hits and Exit Wounds Venture Capitalists achieve their highs from the opium of OPM (that is, Other People's Money) ...so even a bad trip is still a free trip. |
